APOA2 encodes apolipoprotein A-II, a component of HDL. A common SNP (rs5082) has been linked to differences in dietary intake and weight regulation. Some studies suggest that carriers of the risk variant (C allele) may be more sensitive to saturated fat and lose less weight on high-fat diets. However, effect sizes are small and findings are inconsistent. Evidence comes mainly from GWAS and mechanistic studies, not large RCTs. A DNA test alone cannot predict or guarantee weight loss. Lifestyle factors such as calorie balance, macronutrient composition, and physical activity have a much larger impact. Consumers should not rely on single genes but on evidence-based dietary strategies. MyBody-X tests may be motivational, but the clinical relevance of APOA2 for weight loss is limited. Conclusion: There is a scientific link, but it is weak and not sufficiently validated for personalized diet recommendations.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-6509ea1c800fa4e09caac0e5